270. Synthetic Health Data and CodeRx feat. Dr. Joey LeGrand

270. Synthetic Health Data and CodeRx feat. Dr. Joey LeGrand

Intended Audience: Everyone

On today's episode originally recorded in April 2021, we had the opportunity to speak with Dr. Joey LeGrand about synthetic health data and the CodeRx community.

CodeRx is the recent winner of the ONC Synthetic Health Data Challenge! CodeRx's project focused on creation of a medication diversification tool as it pertains to health care data and medication-focused synthetic data.

To learn more about Team CodeRx's entry, visit https://www.challenge.gov/assets/netlify-uploads/coderx_synthetic-data-solution.pdf

In addition to talking about the Synthetic Health Challenge that CodeRx participated in, Dr. LeGrand also discusses the history of how CodeRx was formed and what other interesting projects the community is working on.

To find out more about CodeRx, visit https://coderx.io/

To reach Dr. LeGrand, visit https://legrand.io/

==========

Interested in learning more about pharmacy informatics? Check out the FREE Introduction to Pharmacy Informatics course at www.pharmacyinformaticsacademy.com !

New to LinkedIn and not sure where to start? Download my free ebook, "Professional Networking Unlocked", at https://www.tonydaopharmd.com/ebook

Follow us on social media!

Twitter: @pharmacyitme

Instagram: @pharmacyinformatics

LinkedIn: https://www.linkedin.com/company/pharmacyitme/

Website: Pharmacy IT & Me

Email: [email protected]

Follow Tony's personal Twitter account at @tonydaopharmd

Network with other pharmacists at Pharmacists Connect!

http://pharmacistsconnect.com

For more information on pharmacy informatics, check out some of the following useful links:

ASHP's Section of Pharmacy Informatics and Technology: https://www.ashp.org/Pharmacy-Informaticist/Section-of-Pharmacy-Informatics-and-Technology/

HIMSS Pharmacy Informatics Community: https://www.himss.org/library/pharmacy-informatics

Disclaimer: Views expressed are my own and do not reflect thoughts and opinions of any entity with which I have been, am now, or will be affiliated.